AA

Andrea Ahnmark

NGM Biopharmaceuticals (United States) US

ORCID 0000-0001-8932-4631
27
Publications
1,095
Citations
14
H-Index
15
i10-Index
0
2yr Mean Cite
-
Cite/Paper
Data combined from OpenAlex . OA = OpenAlex S2 = Semantic Scholar
Verify on Google Scholar

Publication & Citation Trends

Publications

0 total

No publications found.

Research Topics

Adipose Tissue and Metabolism (12) Peroxisome Proliferator-Activated Receptors (7) Lipid metabolism and biosynthesis (7) Liver Disease Diagnosis and Treatment (4) Adipokines, Inflammation, and Metabolic Diseases (4)

Affiliations

NIHR Imperial Biomedical Research Centre
GB 2007 - 2007
NGM Biopharmaceuticals (United States)
US 2026 - 2026
AstraZeneca (Finland)
FI 2022 - 2007
AstraZeneca (Italy)
IT 2022 - 2022
AstraZeneca (Sweden)
SE 2022 - 2005

Share Profile

Comparison Shortlist
0 journals
Est. APC Budget: $0
Compare Now